A share price of Global Medical REIT Inc [GMRE] is currently trading at $6.42, up 0.63%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The GMRE shares have gain 3.05% over the last week, with a monthly amount drifted -5.45%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Berenberg started tracking the stock with Buy rating on October 18, 2024, and set its price target to $11.75. On September 19, 2024, Alliance Global Partners initiated with a Buy rating and assigned a price target of $12 on the stock. Robert W. Baird downgraded its rating to a Neutral but stick to its price target of $9 on October 10, 2022. BMO Capital Markets downgraded its rating to a Market Perform and reduced its price target to $9 on October 06, 2022. In a note dated January 13, 2022, KeyBanc Capital Markets downgraded an Sector Weight rating on this stock.
Global Medical REIT Inc experienced fluctuations in its stock price throughout the past year between $6.05 and $10.35. Currently, Wall Street analysts expect the stock to reach $11 within the next 12 months. Global Medical REIT Inc [NYSE: GMRE] shares were valued at $6.42 at the most recent close of the market. An investor can expect a potential return of 71.34% based on the average GMRE price forecast.
Analyzing the GMRE fundamentals
Trailing Twelve Months sales for Global Medical REIT Inc [NYSE:GMRE] were 154.29M which represents -4.26% decline. Gross Profit Margin for this corporation currently stands at 0.79% with Operating Profit Margin at 0.24%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.01 and Total Capital is 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Global Medical REIT Inc [NYSE:GMRE] is 0.95. Further, the Quick Ratio stands at 0.95. Considering the valuation of this stock, the price to sales ratio is 3.02, the price to book ratio is 0.97 and price to earnings (TTM) ratio is 205.11.
